Publication | Open Access

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study

MedicinePharmacologyColorectal CancerPathologyMetastatic Colorectal CancerCancer TreatmentSecond-line TherapyOncologyRadiation OncologyCancer Research